Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOEX.L Regulatory News (OEX)

  • There is currently no data for OEX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Securities and Cleansing Notice

22 Mar 2022 07:00

RNS Number : 5742F
Oilex Ltd
22 March 2022
 

ASX - RNS Announcement

22 March 2022

 

ASX: OEX

AIM: OEX

 

 

ISSUE OF SECURITIES AND CLEANSING NOTICE

 

(Oilex or the Company) wishes to advise that following shareholder approval received at the 17 February 2022 Shareholder Meeting, it has issued the following securities:

 

· 711,295,152 unquoted options (Placement Options). The Placement Options are exercisable at GBP 0.28 pence (0.518 AUD cents) per share on or before 31 December 2022. The Options were issued to shareholders as a one free attaching unquoted option for every two Placement Shares subscribed for, in the January 2022 placement,

 

· 54,839,185 unquoted options, exercisable at GBP 0.14 pence (0.259 AUD cents) on or before 31 December 2023 (Fee Options), to Novum Securities.

 

Exercise of Options

Novum has now exercised the 54,839,185 unquoted Fee Options into fully paid ordinary shares.

 

AIM Admission and Total Voting Rights

 

Application has been made to the London Stock Exchange plc for the admission of 54,839,185 Shares to trade on AIM (Admission). Admission of the Shares is expected to become effective and dealings to commence at 8.00 a.m. on 24 March 2022. Following Admission, the Company will have 7,167,790,704 shares in issue. The Company does not currently hold any shares in treasury. Accordingly, the total number of voting rights will be 7,167,790,704.

 

Section 708A(5)(e) Statement

 

The Corporations Act (Cth) (Act) restricts the on-sale of securities issued without disclosure, unless the sale is exempt under section 708 or 708A of the Act. By giving this notice, the on sale of the Shares noted above will fall within the exemption in section 708A(5) of the Act.

 

Pursuant to the issue of the 54,839,185 Ordinary Shares on 17 March 2022, Oilex gives notice under section 708A(5)(e) of the Act that:

 

1) Oilex issued the Shares without disclosure to investors under Part 6D.2 of the Act;

 

2) As at the date of this notice, Oilex has complied with:

a) the provisions of Chapter 2M of the Act as they apply to Oilex; and

b) section 674 of the Act; and

 

3) As at the date of this notice, there is no information:

(i) That has been excluded from a continuous disclosure notice in accordance with the ASX Listing Rules; and

(ii) That investors and their professional advisers would reasonably require for the purpose of making an informed assessment of:

A. The assets and liabilities, financial position and performance, profits and losses and prospects of the Company; or

B. The rights and liabilities attaching to the Shares.

 

The relevant Appendix 2A is lodged via ASX on-line forms.

 

For and on behalf of Oilex Ltd

Suzie Foreman

Company Secretary

 

 

 

For further information, please contact:

 

Investor Enquires

Oilex Ltd

Roland Wessel

Chief Executive Officer

Email: oilex@oilex.com.au

Tel: +61 8 9485 3200

Australia

AIM Broker

Novum Securities

Broker

Colin Rowbury

Email: crowbury@novumsecurities.com

Tel: +44 20 7399 9427

UK

AIM Nominated Adviser

Strand Hanson Limited

Nominated Adviser

Rory Murphy/Ritchie Balmer

Email: oilex@strandhanson.co.uk

Tel: +44 20 7409 3494

UK

Media Enquires (UK)

Vigo Communications

Public Relations

Patrick d'Ancona/Chris McMahon

Email: patrick.dancona@vigocomms.com

chris.mcmahon@vigocomms.com

Tel:+ 44 20 7390 0230

UK

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEJTMFTMTJTMFT
Date   Source Headline
24th Oct 20169:56 amRNSQuarterly Report 30 September 2016
24th Oct 20169:08 amRNSOilex Investor Presentation October 2016
24th Oct 20168:58 amRNS2016 Annual Report to Shareholders
24th Oct 20168:33 amRNS2016 AGM Notice of Meeting and Proxy Form
24th Oct 20168:29 amRNS2016 AGM Notice of Meeting
17th Oct 20167:00 amRNSAgreement with GSPC on Cambay-78 Well
29th Sep 20169:03 amRNSAppendix 4G
29th Sep 20169:03 amRNSFinancial Report for year ended 30 June 2016
29th Sep 20168:35 amRNSOilex Corporate Update
25th Aug 20167:00 amRNSExpiry of Unlisted Options
29th Jul 20167:00 amRNSQuarterly Report 30 June 2016
28th Jun 20167:00 amRNSExpiry of Unlisted Options
27th Jun 20167:00 amRNSOilex Investor Presentation June 2016
24th Jun 201610:48 amRNSOilex Corporate Update
10th Jun 201610:17 amRNSAppointment of CFO
8th Jun 20167:00 amRNSZeta Legal Proceedings Settlement
24th May 20168:09 amRNSExecutive Management Changes
18th May 20167:00 amRNSNotification of Major Interest in Shares
17th May 20167:21 amRNSNotification of Major Interest in Shares
6th May 20167:00 amRNSCancellation of Unlisted Options
29th Apr 20168:39 amRNSQuarterly Report 31 March 2016
8th Apr 20167:00 amRNSCommencement of Gas Production from Bhandut Field
18th Mar 20167:00 amRNSOilex Appoints New MD - Jonathan Salomon
18th Mar 20167:00 amRNSAppendix 3Z R Miller
14th Mar 20167:00 amRNSInterim Report 31 December 2015
8th Mar 20167:00 amRNSExpiry of Unlisted Options
1st Mar 20167:00 amRNSZeta Legal Proceedings Update
11th Feb 20167:00 amRNSOilex Strengthens Board with Appointment of NED
11th Feb 20167:00 amRNSAppendix 3X B Lingo
29th Jan 20167:00 amRNSQuarterly Report 31 December 2015
6th Jan 20167:00 amRNSExpiry of Unlisted Options
21st Dec 20157:00 amRNSIndia Operations Update
18th Dec 20157:00 amRNSZeta Legal Proceedings Update
8th Dec 20157:00 amRNSCambay Workover Update
2nd Dec 20159:40 amRNSZeta Legal Proceedings Update
1st Dec 20157:00 amRNSAppendix 3X J Salomon
30th Nov 20157:00 amRNSDirector Appointment
26th Nov 201510:37 amRNSASX Trading Halt
25th Nov 20157:40 amRNSAppendix 3Z J Auld
25th Nov 20157:35 amRNSAppendix 3Z S Bhandari
25th Nov 20157:32 amRNSResults of Annual General Meeting 25 November 2015
25th Nov 20157:00 amRNSCorporate Presentation November 2015
25th Nov 20157:00 amRNSChairman's Address to Shareholders
20th Nov 201512:58 pmRNSAppendix 3Y - S Bhandari
18th Nov 20153:00 pmRNSWithdrawal of Resolution
17th Nov 20151:50 pmRNSIndia Workover Update
13th Nov 20151:00 pmRNSEnd of Trading Halt on ASX
13th Nov 20158:23 amRNSUK Broker
12th Nov 20151:10 pmRNSZeta Update and Legal Proceedings
12th Nov 20157:00 amRNSTrading Halt

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.